WRBY 23.27 (+0.91%)
US93403J1060• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. WRBY

Warby Parker (WRBY) Competitor Comparison

We are evaluating the key criteria listed to compare Warby Parker (WRBY) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

22 / 44

Gross Profits

20 / 40

Total Revenue

20 / 43

EBITDA

38 / 44

Free Cashflow

22 / 44

Quick Ratio

26 / 44

Earnings per Share

23 / 44

Dividend yield

0 / 13

Total Cash

18 / 44

Performance 3 years

32 / 44

Performance 5 years

35 / 44

Performance 10 years

35 / 44

Linearity 3 years

36 / 44

Linearity 5 years

36 / 44

Linearity 10 years

21 / 44

Total Rank

40 / 44

Dividend Rank

43 / 44

Valuation Rank

10 / 44

Piotroski Rank

34 / 44

Muliplier Rank

29 / 44

Performance 5 years - WRBY ranking 35 / 44

These are the competitors of Warby Parker in the industry Medical Instruments & Supplies ranked by performance 5 years
1. Pro-Dex PDEX
304.48
2. Merit Medical Systems MMSI
290.43
3. LeMaitre Vascular LMAT
199.2
4. Glaukos GKOS
120.56
5. West Pharmaceutical Services WST
110.9
6. Repligen RGEN
71.89
7. Hologic HOLX
67.59
8. ResMed RMD
61.22
9. BioLife Solutions BLFS
53.66
10. Steris STE
49.3
11. Alcon ALC
44.68
12. Cooper Companies COO
32.98
13. iRhythm Technologies IRTC
32.36
14. AtriCure ATRC
25.61
15. Pulse Biosciences PLSE
20.07
16. Masimo MASI
10.16
17. Bausch & Lomb BLCO
5.78
18. ICU Medical ICUI
-1.66
19. Intuitive Surgical ISRG
-5.67
20. Harvard Bioscience HBIO
-9.49
21. Becton, Dickinson BDX
-9.98
22. Staar Surgical STAA
-20.82
23. Haemonetics HAE
-24.12
24. KORU Medical Systems KRMD
-27.53
25. NexGel NXGL
-27.73
26. Envista Holdings NVST
-29.22
27. Ansell PD1.F
-30.89
28. Utah Medical Products UTMD
-32.16
29. electroCore ECOR
-38.32
30. Atrion ATRI
-40.35
31. Teleflex TFX
-43.63
32. OraSure Technologies OSUR
-51.04
33. AngioDynamics ANGO
-54.36
34. Baxter BAX
-60.32
35. Warby Parker WRBY
-60.52
36. Dentsply Sirona XRAY
-68.23
37. NovoCure NVCR
-79.51
38. Nephros NEPH
-81.28
39. NeuroMetrix NURO
-83.08
40. Akoya Biosciences AKYA
-87.96
41. Microbot Medical MBOT
-88.31
42. Femasys FEMY
-92.74
43. Ekso Bionics Holdings EKSO
-94.05
44. Predictive Oncology POAI
-99.18
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.